Skip to main content
Top
Published in: Tumor Biology 12/2015

01-12-2015 | Research Article

Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses

Authors: Ugo Borges Pinheiro, Carlos Alberto de Carvalho Fraga, Danilo Cangussu Mendes, Lucyana Conceição Farias, Cláudio Marcelo Cardoso, Christine Mendes Silveira, Marcos Flávio Silveira Vasconcelos D̕Angelo, Kimberly Marie Jones, Sérgio Henrique Souza Santos, Alfredo Maurício Batista de Paula, André Luiz Sena Guimarães

Published in: Tumor Biology | Issue 12/2015

Login to get access

Abstract

It is estimated that 7.6 million people will die as a consequence of head and neck squamous cell carcinoma (HNSCC). Genetic predisposition has emerged as an important risk factor in the development and prognosis of HNSCC. Considering this, the aim of the current study is to assess whether codon 72 SNP of the TP53 gene (rs1042522) is associated with an increased odds ratio of developing HNSCC or with a worse prognosis in patients with HNSCC. Analysis of the rs1042522 in HNSCC patients and in control individuals. Differences between the case and control groups were determined using chi-squared tests. Multivariate analysis was performed to evaluate the odds ratio of HNSCC. Fussy C Means Clustering was to cluster HNSCC patients for survival analyses. Time of survival was calculated using the Kaplan-Meier estimator and comparing this to the log rank test. Statistical significance was set at p < 0.05. A total of 71.4 % of the Arg/Arg genotype were from HNSCC patients, while only 28.6 % of Arg/Arg genotype were found in the control group. Logistic regression demonstrated that the Arg/Arg genotype, smoking, and alcohol consumption increase the odds ratio of HNSCC. No association between TP53 codon 72 polymorphism and P53 expression. No association between rs1042522 and survival or prognoses was observed. This study identified that individuals carrying the arginine allele at rs1042522 have an increased odds ratio of HNSCC. However, no association between codon 72 SNP of the TP53 gene and HNSCC prognosis or P53 expression was observed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
go back to reference (INCA) NCI: Estimate 2014: Brazilian cancer incidence.: Instituto Nacional deCâncer. 2014. (INCA) NCI: Estimate 2014: Brazilian cancer incidence.: Instituto Nacional deCâncer. 2014.
3.
go back to reference De Paula AM, Souza LR, Farias LC, Correa GT, Fraga CA, Eleuterio NB, et al. Analysis of 724 cases of primary head and neck squamous cell carcinoma (hnscc) with a focus on young patients and p53 immunolocalization. Oral Oncol. 2009;45:777–82.CrossRefPubMed De Paula AM, Souza LR, Farias LC, Correa GT, Fraga CA, Eleuterio NB, et al. Analysis of 724 cases of primary head and neck squamous cell carcinoma (hnscc) with a focus on young patients and p53 immunolocalization. Oral Oncol. 2009;45:777–82.CrossRefPubMed
4.
go back to reference Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev. 2005;24:9–17.CrossRefPubMed Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev. 2005;24:9–17.CrossRefPubMed
5.
go back to reference Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH. A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. Cancer Epidemiol Biomark Prev. 1991;1:67–73. Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH. A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. Cancer Epidemiol Biomark Prev. 1991;1:67–73.
6.
go back to reference Wang JR, Gramling SJ, Goldstein DP, Cheng D, Chen D, Azad AK, et al. Association of two brm promoter polymorphisms with head and neck squamous cell carcinoma risk. Carcinogenesis. 2013;34:1012–7.CrossRefPubMed Wang JR, Gramling SJ, Goldstein DP, Cheng D, Chen D, Azad AK, et al. Association of two brm promoter polymorphisms with head and neck squamous cell carcinoma risk. Carcinogenesis. 2013;34:1012–7.CrossRefPubMed
7.
go back to reference Thakur N, Hussain S, Nasare V, Das BC, Basir SF, Bharadwaj M. Association analysis of p16 (cdkn2a) and rb1 polymorphisms with susceptibility to cervical cancer in indian population. Mol Biol Rep. 2012;39:407–14.CrossRefPubMed Thakur N, Hussain S, Nasare V, Das BC, Basir SF, Bharadwaj M. Association analysis of p16 (cdkn2a) and rb1 polymorphisms with susceptibility to cervical cancer in indian population. Mol Biol Rep. 2012;39:407–14.CrossRefPubMed
8.
go back to reference Fonseca-Silva T, Oliveira MV, Fraga CA, Farias LC, Gomes EP, Barros LO, et al. Dnmt3b (c46359t) polymorphisms and immunoexpression of dnmt3b and dnmt1 proteins in oral lichen planus. Pathobiology. 2012;79:18–23.CrossRefPubMed Fonseca-Silva T, Oliveira MV, Fraga CA, Farias LC, Gomes EP, Barros LO, et al. Dnmt3b (c46359t) polymorphisms and immunoexpression of dnmt3b and dnmt1 proteins in oral lichen planus. Pathobiology. 2012;79:18–23.CrossRefPubMed
9.
go back to reference Alves LR, Fraga CA, Oliveira MV, Sousa AA, Jorge AS, Marques-Silva L, et al. High hif-1alpha expression genotypes increase odds ratio of oral cancer. Head Neck Oncol. 2012;4:87. Alves LR, Fraga CA, Oliveira MV, Sousa AA, Jorge AS, Marques-Silva L, et al. High hif-1alpha expression genotypes increase odds ratio of oral cancer. Head Neck Oncol. 2012;4:87.
10.
go back to reference Fraga CA, Sousa AA, Correa GT, Jorge AS, Jesus SF, Jones KM, et al. High hypoxia-inducible factor-1alpha expression genotype associated with eastern cooperative oncology group performance in head and neck squamous cell carcinoma. Head Neck Oncol. 2012;4:77. Fraga CA, Sousa AA, Correa GT, Jorge AS, Jesus SF, Jones KM, et al. High hypoxia-inducible factor-1alpha expression genotype associated with eastern cooperative oncology group performance in head and neck squamous cell carcinoma. Head Neck Oncol. 2012;4:77.
11.
go back to reference Dutra RL, de Carvalho MB, Dos Santos M, Mercante AM, Gazito D, de Cicco R, et al. Fgfr4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx. PLoS One. 2012;7:e50747.CrossRefPubMedPubMedCentral Dutra RL, de Carvalho MB, Dos Santos M, Mercante AM, Gazito D, de Cicco R, et al. Fgfr4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx. PLoS One. 2012;7:e50747.CrossRefPubMedPubMedCentral
12.
go back to reference Lee JM, Yang PW, Yang SY, Chuang TH, Tung EC, Chen JS, et al. Genetic variants in DNA repair predicts the survival of patients with esophageal cancer. Ann Surg. 2011;253:918–27.CrossRefPubMed Lee JM, Yang PW, Yang SY, Chuang TH, Tung EC, Chen JS, et al. Genetic variants in DNA repair predicts the survival of patients with esophageal cancer. Ann Surg. 2011;253:918–27.CrossRefPubMed
13.
go back to reference Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, et al. Aurora-a and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in caucasians. Clin Cancer Res. 2007;13:3100–4.CrossRefPubMedPubMedCentral Chen J, Li D, Wei C, Sen S, Killary AM, Amos CI, et al. Aurora-a and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in caucasians. Clin Cancer Res. 2007;13:3100–4.CrossRefPubMedPubMedCentral
14.
go back to reference Zheng Y, Shen H, Sturgis EM, Wang LE, Shete S, Spitz MR, et al. Haplotypes of two variants in p16 (cdkn2/mts-1/ink4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev. 2002;11:640–5.PubMed Zheng Y, Shen H, Sturgis EM, Wang LE, Shete S, Spitz MR, et al. Haplotypes of two variants in p16 (cdkn2/mts-1/ink4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev. 2002;11:640–5.PubMed
15.
go back to reference Stefani FA, Viana MB, Dupim AC, Brito JA, Gomez RS, da Costa JE, et al. Expression, polymorphism and methylation pattern of interleukin-6 in periodontal tissues. Immunobiology. 2012;218:2012–7. Stefani FA, Viana MB, Dupim AC, Brito JA, Gomez RS, da Costa JE, et al. Expression, polymorphism and methylation pattern of interleukin-6 in periodontal tissues. Immunobiology. 2012;218:2012–7.
16.
go back to reference Dutra WO, Moreira PR, Souza PE, Gollob KJ, Gomez RS. Implications of cytokine gene polymorphisms on the orchestration of the immune response: Lessons learned from oral diseases. Cytokine Growth Factor Rev. 2009;20:223–32.CrossRefPubMed Dutra WO, Moreira PR, Souza PE, Gollob KJ, Gomez RS. Implications of cytokine gene polymorphisms on the orchestration of the immune response: Lessons learned from oral diseases. Cytokine Growth Factor Rev. 2009;20:223–32.CrossRefPubMed
17.
go back to reference Correa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, Dos Santos EP, Silva TF, et al. Association of -308 tnf-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol. 2011;47:888–94.CrossRefPubMed Correa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, Dos Santos EP, Silva TF, et al. Association of -308 tnf-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol. 2011;47:888–94.CrossRefPubMed
18.
go back to reference Farias LC, Fraga CA, De Oliveira MV, Silva TF, Marques-Silva L, Moreira PR, et al. Effect of age on the association between p16cdkn2a methylation and dnmt3b polymorphism in head and neck carcinoma and patient survival. Int J Oncol. 2010;37:167–76.PubMed Farias LC, Fraga CA, De Oliveira MV, Silva TF, Marques-Silva L, Moreira PR, et al. Effect of age on the association between p16cdkn2a methylation and dnmt3b polymorphism in head and neck carcinoma and patient survival. Int J Oncol. 2010;37:167–76.PubMed
19.
go back to reference McBride OW, Merry D, Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci U S A. 1986;83:130–4.CrossRefPubMedPubMedCentral McBride OW, Merry D, Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci U S A. 1986;83:130–4.CrossRefPubMedPubMedCentral
22.
go back to reference Xu T, Xu ZC, Zou Q, Yu B, Huang XE. P53 arg72pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in asians but not caucasians. Asian Pac J Cancer Prev. 2012;13:2349–54.CrossRefPubMed Xu T, Xu ZC, Zou Q, Yu B, Huang XE. P53 arg72pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in asians but not caucasians. Asian Pac J Cancer Prev. 2012;13:2349–54.CrossRefPubMed
23.
go back to reference Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, et al. Tp53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 2009;10:772–84.CrossRefPubMed Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, et al. Tp53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 2009;10:772–84.CrossRefPubMed
24.
go back to reference Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, et al. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol. 2004;164:1233–41.CrossRefPubMedPubMedCentral Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, et al. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol. 2004;164:1233–41.CrossRefPubMedPubMedCentral
25.
go back to reference Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47–54.CrossRefPubMed Marin MC, Jost CA, Brooks LA, Irwin MS, O’Nions J, Tidy JA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000;25:47–54.CrossRefPubMed
26.
go back to reference Fraga CA, de Oliveira MV, de Oliveira ES, Barros LO, Santos FB, Gomez RS, et al. A high hif-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol. 2012;48:130–5.CrossRefPubMed Fraga CA, de Oliveira MV, de Oliveira ES, Barros LO, Santos FB, Gomez RS, et al. A high hif-1alpha expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol. 2012;48:130–5.CrossRefPubMed
27.
go back to reference Bezdek JC. Pattern recognition with fuzzy objective function algorithms. New York: Plenum Press; 1981.CrossRef Bezdek JC. Pattern recognition with fuzzy objective function algorithms. New York: Plenum Press; 1981.CrossRef
28.
go back to reference Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. Tp53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007;26:2157–65.CrossRefPubMed Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. Tp53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007;26:2157–65.CrossRefPubMed
29.
go back to reference Cadoni G, Boccia S, Petrelli L, Di Giannantonio P, Arzani D, Giorgio A, et al. A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. Acta Otorhinolaryngol Ital. 2012;32:1–11.PubMedPubMedCentral Cadoni G, Boccia S, Petrelli L, Di Giannantonio P, Arzani D, Giorgio A, et al. A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. Acta Otorhinolaryngol Ital. 2012;32:1–11.PubMedPubMedCentral
30.
go back to reference Correa GT, Bandeira GA, Cavalcanti BG, Santos FB, Neto JF, Guimaraes AL, et al. Analysis of ecog performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival. Support Care Cancer. 2012;20:2679–85.CrossRefPubMed Correa GT, Bandeira GA, Cavalcanti BG, Santos FB, Neto JF, Guimaraes AL, et al. Analysis of ecog performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival. Support Care Cancer. 2012;20:2679–85.CrossRefPubMed
31.
go back to reference Suresh K, Chandirasekar R, Kumar BL, Venkatesan R, Sasikala K. No association between the trp53 codon 72 polymorphism and head and neck cancer: a case-control study in a south indian population. Asian Pac J Cancer Prev. 2010;11:1749–53.PubMed Suresh K, Chandirasekar R, Kumar BL, Venkatesan R, Sasikala K. No association between the trp53 codon 72 polymorphism and head and neck cancer: a case-control study in a south indian population. Asian Pac J Cancer Prev. 2010;11:1749–53.PubMed
32.
go back to reference Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002;183:123–30.CrossRefPubMed Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002;183:123–30.CrossRefPubMed
33.
go back to reference Papadakis ED, Soulitzis N, Spandidos DA. Association of p53 codon 72 polymorphism with advanced lung cancer: the arg allele is preferentially retained in tumours arising in arg/pro germline heterozygotes. Br J Cancer. 2002;87:1013–8.CrossRefPubMedPubMedCentral Papadakis ED, Soulitzis N, Spandidos DA. Association of p53 codon 72 polymorphism with advanced lung cancer: the arg allele is preferentially retained in tumours arising in arg/pro germline heterozygotes. Br J Cancer. 2002;87:1013–8.CrossRefPubMedPubMedCentral
34.
go back to reference Brant O, Hoffmann M, Kanappilly A, Gorogh T, Gottschlich S. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region. Anticancer Res. 2007;27:3301–5.PubMed Brant O, Hoffmann M, Kanappilly A, Gorogh T, Gottschlich S. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region. Anticancer Res. 2007;27:3301–5.PubMed
35.
go back to reference Ferreira da Silva I, Koifman RJ, Quinto Santos Souza C, Ferreira de Almeida Neto O, Koifman S. Tp53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of brazilian women with cervical lesions. J Toxicol Environ Health A. 2010;73:888–900.CrossRefPubMed Ferreira da Silva I, Koifman RJ, Quinto Santos Souza C, Ferreira de Almeida Neto O, Koifman S. Tp53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of brazilian women with cervical lesions. J Toxicol Environ Health A. 2010;73:888–900.CrossRefPubMed
36.
go back to reference Singhal P, Hussain S, Thakur N, Batra S, Salhan S, Bhambani S, et al. Association of mdm2 and p53 polymorphisms with the advancement of cervical carcinoma. DNA Cell Biol. 2013;32:19–27.CrossRefPubMed Singhal P, Hussain S, Thakur N, Batra S, Salhan S, Bhambani S, et al. Association of mdm2 and p53 polymorphisms with the advancement of cervical carcinoma. DNA Cell Biol. 2013;32:19–27.CrossRefPubMed
37.
go back to reference Dumont P, Leu JI, Della Pietra 3rd AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65.CrossRefPubMed Dumont P, Leu JI, Della Pietra 3rd AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65.CrossRefPubMed
38.
go back to reference Jing G, Lv K, Jiao X. The p53 codon 72 polymorphism and the risk of oral cancer in a chinese han population. Genet Test Mol Biomarkers. 2012;16:1149–52.CrossRefPubMed Jing G, Lv K, Jiao X. The p53 codon 72 polymorphism and the risk of oral cancer in a chinese han population. Genet Test Mol Biomarkers. 2012;16:1149–52.CrossRefPubMed
39.
go back to reference Jiang M, Chiu SY, Hsu W. Sumo-specific protease 2 in mdm2-mediated regulation of p53. Cell Death Differ. 2011;18:1005–15.CrossRefPubMed Jiang M, Chiu SY, Hsu W. Sumo-specific protease 2 in mdm2-mediated regulation of p53. Cell Death Differ. 2011;18:1005–15.CrossRefPubMed
40.
go back to reference Linder S, Parrado C, Falkmer UG, Blasjo M, Sundelin P, von Rosen A. Prognostic significance of ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies mib-1 and do-7 in formalin-fixed paraffin-embedded tumour material. Br J Cancer. 1997;76:54–9.CrossRefPubMedPubMedCentral Linder S, Parrado C, Falkmer UG, Blasjo M, Sundelin P, von Rosen A. Prognostic significance of ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies mib-1 and do-7 in formalin-fixed paraffin-embedded tumour material. Br J Cancer. 1997;76:54–9.CrossRefPubMedPubMedCentral
41.
go back to reference Shinohara S, Kikuchi M, Tona R, Kanazawa Y, Kishimoto I, Harada H, et al. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas. Jpn J Clin Oncol. 2014;44:232–40.CrossRefPubMed Shinohara S, Kikuchi M, Tona R, Kanazawa Y, Kishimoto I, Harada H, et al. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas. Jpn J Clin Oncol. 2014;44:232–40.CrossRefPubMed
42.
go back to reference de Oliveira MV, Pereira Gomes EP, Pereira CS, de Souza LR, Barros LO, Mendes DC, et al. Prognostic value of microvessel density and p53 expression on the locoregional metastasis and survival of the patients with head and neck squamous cell carcinoma. Appl Immunohistochem Mol Morphol: AIMM / Off Publ Soc Appl Immunohistochem. 2013;21:444–51.CrossRef de Oliveira MV, Pereira Gomes EP, Pereira CS, de Souza LR, Barros LO, Mendes DC, et al. Prognostic value of microvessel density and p53 expression on the locoregional metastasis and survival of the patients with head and neck squamous cell carcinoma. Appl Immunohistochem Mol Morphol: AIMM / Off Publ Soc Appl Immunohistochem. 2013;21:444–51.CrossRef
43.
go back to reference Wang Z, Sturgis EM, Guo W, Song X, Zhang F, Xu L, et al. Association of combined p73 and p53 genetic variants with tumor hpv16-positive oropharyngeal cancer. PLoS One. 2012;7:e35522.CrossRefPubMedPubMedCentral Wang Z, Sturgis EM, Guo W, Song X, Zhang F, Xu L, et al. Association of combined p73 and p53 genetic variants with tumor hpv16-positive oropharyngeal cancer. PLoS One. 2012;7:e35522.CrossRefPubMedPubMedCentral
44.
go back to reference Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, et al. Biomarkers of hpv in head and neck squamous cell carcinoma. Cancer Res. 2012;72:5004–13.CrossRefPubMedPubMedCentral Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, et al. Biomarkers of hpv in head and neck squamous cell carcinoma. Cancer Res. 2012;72:5004–13.CrossRefPubMedPubMedCentral
45.
go back to reference Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene. 2004;23:3328–37.CrossRefPubMed Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene. 2004;23:3328–37.CrossRefPubMed
Metadata
Title
Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses
Authors
Ugo Borges Pinheiro
Carlos Alberto de Carvalho Fraga
Danilo Cangussu Mendes
Lucyana Conceição Farias
Cláudio Marcelo Cardoso
Christine Mendes Silveira
Marcos Flávio Silveira Vasconcelos D̕Angelo
Kimberly Marie Jones
Sérgio Henrique Souza Santos
Alfredo Maurício Batista de Paula
André Luiz Sena Guimarães
Publication date
01-12-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3677-7

Other articles of this Issue 12/2015

Tumor Biology 12/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine